MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202641106009 A) filed by Saveetha Institute Of Medical And Technical Sciences on September 03, 2026, for Digital Therapeutics Adherence Support System.
Inventors include T. Satwik; Dr. R. Arangasamy; Dr. Alden Jason; and Dr Ramya Mohan.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The Digital Therapeutics Adherence Support System (DTASS) is an intelligent, patient-centered platform designed to improve compliance with prescribed digital therapeutic interventions. Traditional healthcare delivery often struggles with patient adherence due to lack of motivation, poor monitoring, and limited personalized support. This invention introduces a smart, sensorintegrated, and microcontroller-driven system that leverages mobile applications, wearable devices, and cloud-based analytics to track, remind, and encourage patients in real time. The system integrates adherence monitoring, personalized feedback, and automated alerts to healthcare providers, ensuring safe, efficient, and sustainable therapeutic outcomes. By combining embedded systems, Al-driven analytics, and smart sensing technology, DTASS transforms digital therapeutics into a more reliable, patient-friendly, and effective process.
Disclaimer: Curated by HT Syndication.
